• A Cure for Sickle Cell Disease
• A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction
• A Rare Case of Multiple Bone Infarctions and Abnormal Pulmonary Function Tests in a Patient With Compound Heterozygous Hemoglobin S and Type 2 Hereditary Persistence of Fetal Hemoglobin
• Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study
• Acute chest syndrome in sickle cell disease
• Acute painful crisis in adults with sickle cell disease
• Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement
• Association between fetal hemoglobin, lactate dehydrogenase, and disease severity in patients with sickle cell disease at Bugando Medical Centre, Mwanza, Tanzania
• Atrial Arrhythmia in Sickle Cell Anemia Adults: A missing link towards understanding and preventing strokes
• Blood pressure and electrocardiographic profile of children with sickle cell anaemia in steady-state and vaso-occlusive crisis
• Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease
• Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant
• Cell and gene therapy accessibility
• Challenges in Implementing a Total Hip Arthroplasty Program in a Developing Country: Our Experience at Monkole Hospital in the Democratic Republic of Congo
• Choledochal Cyst in the Context of Sickle Cell Disease: A Case Report
• Chronic automated red cell exchange therapy for sickle cell disease
• Clinical Features in Paediatric Sickle Cell Anaemia Cases from Rajasthan, India: A Case Series
• Clinical Profile and middle cerebral artery velocity of children with sickle cell anaemia seen in UUTH, Uyo, Akwa Ibom state, Nigeria
• Clinical, aetiological and therapeutic features of severe sickle cell related vaso-occlusive crisis at the Sylvanus Olympio University Hospital, Lome
• Cognitive outcomes of children and adults with sickle cell anaemia: A contemporary cohort
• Current and emerging drug treatment strategies to tackle sickle cell anemia
• Degree of PEGylatation of <em>Lumbricus terrestris</em> Hemoglobin Improves Microcirculatory Blood Flow but Increases the Rate of Auto-Oxidation
• delta (9) -Tetrahydrocannabinol alleviates hyperalgesia in a humanized mouse model of sickle cell disease
• Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias - pilot study protocol
• Detection of Subclinical Cardiac Dysfunction in Patients with Sickle Cell Disease using Speckle Tracking Echocardiography
• Developing a pill to treat sickle cell disease
• Diagnostic accuracy of mean corpuscular volume in detecting coexisting iron deficiency in patients of sickle cell disorders: A hospital-based study
• Diagnostic and Therapeutic Challenges in Intravenous Mercury Poisoning: A Case Report
• Differential sensitivity to hypoxia enables shape-based classification of sickle cell disease and trait blood samples at point of care
• Does deteriorating antioxidant defense and impaired gamma-glutamyl cycle induce oxidative stress and hemolysis in individuals with sickle cell disease?
• Eliminating Health Care Access and Quality Inequities in Sickle Cell Disease: Policy Lessons from the End Sepsis Initiative
• Emergency department management of patients with sickle cell disease
• Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease
• EPCR shedding light on sickle nephropathy
• Etiology, Outcomes, and Complications of Total Hip Arthroplasty in Younger Patients: A Nationwide Big Data Analysis
• Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases
• Evaluation of peripheral blood inflammatory biomarkers in sickle cell disease with and without retinopathy
• Exercise and training in sickle cell disease: Safety, potential benefits, and recommendations
• Fat Embolism Syndrome Mimicking Thrombotic Thrombocytopenic Purpura in a Patient With Hemoglobin S/Beta-Thalassemia
• Ferroptosis as an emerging target in sickle cell disease
• Genome editing in K562 cells suggests a functional role for the XmnI Gg polymorphism: a widely used genetic marker in beta-thalassemia and sickle cell disease patients
• Genotyping the BCL11A Single Nucleotide Polymorphism and Associated Levels of Fetal Hemoglobin in Mauritanian Sickle Cell Patients
• Harnessing the evolving CRISPR/Cas9 for precision oncology
• Hospitalization Events Among Adolescents and Adults With Sickle Cell Disease in a Tertiary Care Center in Central India
• Human erythrocytes' perplexing behaviour: erythrocytic microRNAs
• Hydroxyurea in the sickle cell disease modern era
• Hydroxyurea maintains working memory function in pediatric sickle cell disease
• Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial
• Intracranial aneurysms in sickle cell disease are associated with hemodynamic stress and anemia
• Laparoscopic cholecystectomy for symptomatic cholelithiasis in children and adolescents: analysis of 50 cases from a single institution
• Measurement of left atrial size as a predictor of severity of illness in sickle cell disease
• Medicaid Coverage in Early Childhood for Children With Sickle Cell Disease
• Methemoglobin aggregation is modulated by the anti-sickling drug voxelotor
• Molecular characterization of HAMP rs10421768 gene and phenotypic expression of hepcidin; a case-control study among sickle cell anaemia patients in Ghana
• Novel Peri-Operative Strategy for Sickle Cell Disease with Tetralogy of Fallot
• Obiageli Nnodu: sickle cell disease in Africa's largest nation
• Optimizing the management of inherited blood disorders in a changing market: Findings from the AMCP Market Insights Program
• Other Wounds Encountered in Clinical Practice
• Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
• Patient Evaluation of Patient-Controlled Analgesia for Pain Crises in Sickle Cell Disease
• People with sickle cell disease face damaging stigma
• Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study
• PGC-1alpha agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease
• Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease
• Position paper on advancing sickle cell disease management in France by bridging the clinical practices and guidelines through expert insights
• Post-GWAS Validation of Target Genes Associated with HbF and HbA₂ Levels
• Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies
• Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies
• Prediction of Functional Academic Outcomes by Fine Motor Skills in Individuals With Sickle Cell Disease
• Presentation of Acute Pancreatitis in Sickle Cell Disease Patients: A Single Hospital Experience
• Prevalence of Pulmonary Hypertension among Sudanese Patients with Sickle Cell Disease
• Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study
• Prevalence, patterns, and factors associated with abnormal lung function among children with sickle cell disease in Uganda: a cross-sectional study
• Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes
• Providing the Tools to Facilitate Quality Care for Children with Sickle Cell Disease
• Radiofrequency Ablation (RFA) for Osteoid Osteoma in an 11-Year-Old Male Child With Sickle Cell Trait: A Case Report
• Recurrent haemorrhagic venous infarct in a patient with sickle cell disease
• Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia
• Sex-disaggregated analysis of acute kidney injury in hospitalized children with sickle cell anemia in Uganda
• Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study
• Sickle cell disease - common and dangerous complications
• Sickle Cell Disease and Gut Health: The Influence of Intestinal Parasites and the Microbiome on Angolan Children
• Studies of Exagamglogene Autotemcel - Age and Place
• Studies of Exagamglogene Autotemcel - Age and Place. Reply
• SURGICAL OUTCOMES IN CONCURRENT SICKLE CELL AND DIABETIC RETINOPATHY
• SURGICAL OUTCOMES OF RETINAL DETACHMENT ASSOCIATED WITH PROLIFERATIVE SICKLE CELL RETINOPATHY
• Targeted therapeutic management based on phytoconstituents for sickle cell anemia focusing on molecular mechanisms: Current trends and future perspectives
• Telomere Dynamics in Sickle Cell Anemia: Unraveling Molecular Aging and Disease Progression
• The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
• The effect on the equilibrium sickle cell allele frequency of the probable protection conferred by malaria and sickle cell gene against other infectious diseases
• The enigma of sickle cell hepatopathy: Pathophysiology, clinical manifestations and therapy
• The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/beta-thalassaemia and no or low HbA expression
• The search for pyruvate kinase-R activators; from a HTS screening hit via an impurity to the discovery of a lead series
• The Ugandan sickle Pan-African research consortium registry: design, development, and lessons
• Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in Tanzania
• Trainees' perspectives on sickle cell education: a qualitative needs assessment
• Transcriptional Repressor BCL11A in Erythroid Cells
• Unpacking the utility of euvolemic automated transfusion in sickle cell disease
• Update on SickleInAfrica: a collaborative and multidimensional approach to conduct research and improve health
• Updates in Pediatric Sickle Cell Lung Disease